Biotechnology
Ceapro Inc. The Company regrets to inform shareholders that Mr. Mark Redmond, Ph.D has decided to step down as a Director and an Officer of the Company effective immediately. In the mean time, Mr. Gilles R. Gagnon, an independent Director of the Company
46 hours ago
Ceapro Inc. The Company regrets to inform shareholders that Mr. Mark Redmond, Ph.D has decided to step down as a Director and an Officer of the Company effective immediately. In the mean time, Mr. Gilles R. Gagnon, an independent Director of the Company
46 hours ago
Protherics PLC announces Interest in Shares
49 hours ago
Protherics PLC announces Issue of Shares
49 hours ago
Shire Limited , the global specialty biopharmaceutical company, will announce second quarter 2008 earnings on Thursday 31 July 2008
54 hours ago
DJohnson Holdings Inc. announces that it acquired voting control and direction over 9,003,400 common shares of MIGENIX Inc. . The Company now has beneficial ownership of and/or voting control and direction over an aggregate of 14,042,400 common shares ,
65 hours ago
Xechem International today announced today that it will be holding a conference call to update shareholders and other interested persons on its business operations and financial status. Details for the call are:
69 hours ago
According to gastroenterologist and President of World Gastroenterology Organization Dr. Eamonn Quigley, your overall health depends on the healthy functioning of your digestive system. Your digestive system not only pulls nutrients from food to nourish
69 hours ago
DARA BioSciences, Inc. will be presenting at 12:30 p.m. on Thursday, July 10, 2008, at the Fourth Annual Collins Stewart Growth Conference in New York City.
70 hours ago
Medivation, Inc. today announced that it will hold a teleconference at 5:00 p.m. EDT on Monday, July 7, to discuss top-line results from its randomized, double-blind, placebo-controlled Phase 2 clinical trial of dimebon in Huntington's disease.
71 hours ago
The Eniva Research Group has released results from aboratory testing by the world-famous Linus Pauling Micronutrient Research Institute at Oregon State University which demonstrated the Eniva Health Supplement VIBE possessed DNA protective anti-mutagenic
72 hours ago
Bioheart, Inc., a biotechnology company that is focused on the development of autologous cell therapies and devices for the treatment of chronic and acute heart damage, today announced that its Board of Directors appointed Howard J. Leonhardt, Bioheart's
72 hours ago
Medicago Inc. a annoncé aujourd'hui l'obtention d'une contribution non remboursable maximale de 279 700 $ dans le cadre du Programme d'aide à la recherche industrielle du Conseil national de recherches du Canada pour soutenir le développement du progr
72 hours ago
Medicago Inc. today announced it has been awarded a non-refundable contribution of up to $279,700 from Canada's National Research Council Industrial Research Assistance Program to support the development of the Company's seasonal influenza Virus-Like Par
72 hours ago
Cell Biosciences, Inc., a provider of ultrasensitive protein detection and characterization systems to life science researchers, today announced three key management team additions.
72 hours ago
1 - 15 of 19615 Stories
<<
<
Next 15 Biotechnology
>
>>